Inflacam

Meloxicam, the active ingredient in Inflacam, is a nonsteroidal anti-inflammatory drug presented as an oral tablet for oral use. It is indicated for the management of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and other musculoskeletal conditions in adult patients.

GNH USA supplies Inflacam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets across Europe, Asia, Africa and the Americas globally.

Meloxicam is an NSAID that reduces inflammation and pain in several musculoskeletal disorders.

- Osteoarthritis: reduces joint pain, stiffness and swelling, helping to improve mobility and daily activities. - Rheumatoid arthritis: diminishes synovial inflammation, decreasing pain and joint tenderness, and may help limit progressive joint destruction. - Musculoskeletal pain: offers analgesic and anti‑inflammatory effects for acute or chronic pain caused by strains, sprains, overuse injuries or other soft‑tissue conditions. - Post‑operative pain: provides short‑term relief of pain and inflammation following surgical procedures, supporting patient comfort and recovery.

Like other NSAIDs, meloxicam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Skin rash or itching.

Serious or Rare Side Effects: - Peptic ulcer disease or gastrointestinal bleeding. - Hepatotoxicity: elevated liver enzymes or hepatitis. - Severe hypersensitivity reactions: anaphylaxis or Stevens‑Johnson syndrome.

When prescribing meloxicam, clinicians should consider several safety precautions to minimize risk.

- Assess renal function: avoid use in patients with severe renal impairment or monitor closely. - Evaluate cardiovascular risk: use cautiously in individuals with history of heart disease or hypertension. - Monitor hepatic status: discontinue if signs of liver injury appear. - Use lowest effective dose: limit duration to the shortest period necessary for symptom control. - Contraindications: do not prescribe to patients with known hypersensitivity to meloxicam or other NSAIDs. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and light.

Meloxicam can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): elevated bleeding risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function, especially in dehydrated patients. - Diuretics: potential for reduced effectiveness and kidney injury. - Lithium: NSAIDs can raise lithium serum levels, risking toxicity.